AAV-GAA gene therapy (Abeona Therapeutics)

N/A

Report date: 2025/01/26 18:17:46

Base Information

Drug NameAAV-GAA gene therapy (Abeona Therapeutics)
Drug Alias Nameacid alpha-glucosidase gene therapy (Abeona Therapeutics)adeno-associated virus based gene therapy (Abeona Therapeutics)AAV214.coGAA
ClassificationOther
Mechanisms of ActionGAA gene transference
TargetsAcidic alpha-glucosidase
Therapy Area/IndicationsGlycogen Storage Disease Type II
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAbeona Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAbeona Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsGlycogen Storage Disease Type II
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A